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Background: Metal borides are a class of inorganic solids that is much less known and investigated than for
example metal oxides or intermetallics. At the same time it is a highly versatile and interesting class of compounds
in terms of physical and chemical properties, like semiconductivity, ferromagnetism, or catalytic activity. This makes
these substances attractive for the generation of new materials. Very little is known about the interaction between
organic materials and borides. To generate nanostructured and composite materials which consist of metal borides
and organic modifiers it is necessary to develop new synthetic strategies. Phage peptide display libraries are
commonly used to select peptides that bind specifically to metals, metal oxides, and semiconductors. Further, these
binding peptides can serve as templates to control the nucleation and growth of inorganic nanoparticles.
Additionally, the combination of two different binding motifs into a single bifunctional phage could be useful for
the generation of new composite materials.
Results: In this study, we have identified a unique set of sequences that bind to amorphous and crystalline nickel
boride (Ni3B) nanoparticles, from a random peptide library using the phage display technique. Using this technique,
strong binders were identified that are selective for nickel boride. Sequence analysis of the peptides revealed that the
sequences exhibit similar, yet subtle different patterns of amino acid usage. Although a predominant binding motif
was not observed, certain charged amino acids emerged as essential in specific binding to both substrates. The 7-mer
peptide sequence LGFREKE, isolated on amorphous Ni3B emerged as the best binder for both substrates. Fluorescence
microscopy and atomic force microscopy confirmed the specific binding affinity of LGFREKE expressing phage to
amorphous and crystalline Ni3B nanoparticles.
Conclusions: This study is, to our knowledge, the first to identify peptides that bind specifically to amorphous and to
crystalline Ni3B nanoparticles. We think that the identified strong binding sequences described here could potentially
serve for the utilisation of M13 phage as a viable alternative to other methods to create tailor-made boride composite
materials or new catalytic surfaces by a biologically driven nano-assembly synthesis and structuring.Background
The diverse group of transition metal borides comprises
compounds that exhibit or combine interesting physical
properties such as semiconductivity, ferromagnetism,
hardness, thermal and mechanical stability and oxidation
resistance [1]. Some of the binary, ternary, and quaternary
metal borides are even superconducting or represent
some of the strongest permanent magnets [2,3]. Because
of the high melting point of boron, the traditional* Correspondence: bernhard.hauer@itb.uni-stuttgart.de
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reproduction in any medium, provided the orsynthesis of metal borides does not result in nanoscale or
nanostructured products. As an alternative, a room
temperature synthesis of nickel boride nanoparticles via
hydrolysis of NaBH4 has been reported [4-7]. Biological
systems, on the other hand, can synthesise materials under
mild and environmentally benign conditions [8]. Nickel
borides like Ni3B, Ni2B or NiB are considered to exhibit
catalytic activity in all kinds of reduction reactions, and
hydrogenation reactions [9-15]. Like iron borides they are
expected to exhibit paramagnetism, ferro- or superpara-
magnetism [16,17]. The electrical conductivities of differ-
ent nickel borides vary with their boron content. Thus,
the nickel-boron system represents an interesting class ofd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions and the potential of bio-modified inorganic solids.
Until now nothing is known about the interaction be-
tween boron-containing materials and peptides, although
peptides binding to solid surfaces have been extensively
exploited for other chemical systems in nanoscale science
because of their material selective properties [18-20]. To
select for peptides that are capable of interacting with in-
organic materials, phage peptide display is a powerful
technique [21]. Phage display is a selection technique in
which a combinatorial library of random peptides (~109)
is expressed as a fusion with an M13 phage coat protein
(usually p3), resulting in the display of the fused peptide
on the surface of the phage particle. Selection of the de-
sired peptides, which is usually a random 7- or 12-amino
acid peptide, is achieved by multiple rounds of target
binding, elution and amplification, a process known as
biopanning (or panning). Because the DNA sequence for
the displayed peptide is genetically fused to the p3 gene,
the amino acid sequence of the phage-displayed peptide is
readily obtained by sequencing the p3 encoding DNA.
Phage display has been used to identify peptides which
specifically bind to metals like Ag, and Pd, and various
inorganic materials like ZnO, SiO2, TiO2, ZnS, and CdS
[22-29]. In the last few years, specific binding peptides
to nickel have also been described [30-32]. Up to now,
no specific binding peptides have been identified for bo-
rides in general, neither nanostructured nor bulk mater-
ial, or more specifically nickel boride nanoparticles. The
identification of such a selective binding peptide se-
quence would be a first, significant step towards
peptide-modified boride materials and composites. Such
linkers would help to make boride particles available for
biological systems and allow for a tuning of the proper-
ties of borides using a biological peptide-enabled nano-
assembly process.
Since to our knowledge no binding peptides to boride
nanoparticles are described in the literature, our aim of
this research was to identify peptides that bind specific-
ally to metallic borides. This constitutes the first step in
order to combine two different binding motifs e.g. a me-
tallic and a ceramic boride into a single bifunctional
phage or into a synthetic bifunctional peptide. This
would be useful for the generation of new boride com-
posite materials in which the physical properties of two
different borides are unified which is until now not com-
binable. Peptides were selected after several rounds of
screening with a commercial phage library. Several
Ni3B-binding peptides were selected using nanoparticles
of amorphous and crystalline Ni3B as targets. From the
initial library, we identified ten phages that exhibit se-
lective binding to either amorphous or crystalline or
both using titer count analysis, fluorescence and atomic
force microscopy.Results and discussion
Isolation of Ni3B-binding peptides
To identify Ni3B-binding peptides, a commercial available
M13 bacteriophage display library (Ph.D.-7; New England
Biolabs) was screened against amorphous and crystalline
Ni3B nanoparticles. In the Ph.D.-7 library, random linear
heptapeptides are displayed as N-terminal fusions to the
minor coat protein p3 of M13. The M13 phage p3 con-
structs used in the screening selection have five copies of
the peptide displayed on the one end of the phage particle.
Five rounds of biopanning were conducted for each of the
amorphous and crystalline Ni3B substrates. Each biopan-
ning round involved the steps of phage binding, removal
of weak binding affinity phage by washing, and elution of
bound phage by a rapid pH decrease. More stringent
washing conditions were used in the additional rounds of
panning. A 0.3% TBST wash solution was used to remove
phage with low binding affinity to Ni3B during the second
round, whereas 0.5%, 0.6%, and 0.8% TBST wash solutions
were used for the third, fourth, and fifth round, respect-
ively. A total of 58 phage clones were selected and ana-
lysed by DNA sequencing after the fourth and fifth round
of biopanning against amorphous and crystalline Ni3B
substrates. For amorphous Ni3B substrates, 30 peptides
were identified coding for 15 different peptide sequences
(designated with an A for amorphous). A summary of the
peptides identified from biopanning against amorphous
Ni3B is provided in Table 1. In the case of the biopanning
against crystalline Ni3B substrates, 28 peptides were
isolated coding for 28 different peptide sequences (des-
ignated with a C for crystalline) shown in Table 2. The
fact that all the peptides which were identified for crys-
talline Ni3B are different, could be an indication of a
more complex surface structure for crystalline Ni3B
nanoparticles than for amorphous Ni3B nanoparticles.
Interestingly, one peptide sequence, ANHQSAN, termed
A6/C28, was isolated from both, amorphous and crystal-
line, Ni3B substrates. While most of the peptides, espe-
cially identified for the crystalline Ni3B substrate, were
isolated only once, for the amorphous substrate the pep-
tide A1 was isolated eight-times, A2 six-times, and A3
four-times, respectively.
Characteristics of the identified binding peptides
Due to the fact that cysteines interfere with the p3-
mediated M13 infection process, no cysteines were
present in the identified binding peptides [33]. The bind-
ing peptides showed approximately three-times more
positively charged residues (K, R, and H) than negatively
charged residues (D and E) (Table 3). Compared with
the peptides binding to amorphous Ni3B, the binding
peptides to crystalline nickel boride show a two-times
higher occurrence of the positively charged amino acids
arginine and lysine, and a three-times higher occurrence
Table 1 Summary of the isolated binding peptides to amorphous Ni3B
Peptide Frequency Sequence Number of functional amino acid residues pI
Basic Acidic Hydrophobic
A4 1/30 SEIVDNH 1 2 2 4.35
A1 8/30 TNLTLAS 0 0 3 5.19
A2 6/30 GALPNNL 0 0 3 5.52
A8 1/30 NVNSTSF 0 0 2 5.52
A9 1/30 SPDTVQK 1 1 1 5.55
A10 1/30 GNRLSAD 1 1 2 5.84
A7 1/30 LGFREKE 2 2 2 6.14
A11 1/30 TQVYHPM 1 0 3 6.40
A6 1/30 ANHQSAN 1 0 2 6.19
A5 1/30 TNSSFHK 2 0 1 8.44
A12 1/30 NTVIYQK 1 0 3 8.59
A13 1/30 HVQYWQF 2 0 3 8.75
A3 4/30 SLAVSRS 1 0 3 9.47
A14 1/30 VSVNSRT 1 0 2 9.72
A15 1/30 RLLNPWI 1 0 4 9.75
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charged amino acids in the library is comparable in fre-
quency, the increased abundance of these amino acids
within the identified sequences could be possibly attrib-
uted to the surface composition of the nickel borides.
The characterisation of the surface of different amorph-
ous nickel borides by Okamoto et al. and Caputo et al.
by X-ray photoelectron spectroscopy (XPS) and X-ray
diffraction (XRD), respectively, revealed that the electron
densities on nickel are increased by electron transfer
from boron to the metal [6,34]. Based on the shift of the
charge, specific binding peptides could therefore interact
with the nickel boride substrates via electrostatic interac-
tions. The majority of the peptides identified on Ni3B
prevalently possess alanine, leucine, proline, serine and
threonine residues (Figure 1) which is a consequence of
the amino acid distribution of the applied phage display
library. In addition, the binding peptides identified on
amorphous Ni3B possess 2.5-times more asparagine resi-
dues as compared with the peptides identified on crys-
talline Ni3B. This is vice versa with proline residues
binding to crystalline Ni3B. The strong presence of as-
paragine in the peptide sequences binding to amorphous
Ni3B, and asparagine and histidine in the peptide se-
quences binding to crystalline Ni3B suggests that the
binding between the Ni3B and peptides could further-
more occur via hydrogen bonding interactions. The al-
most complete absence of tryptophan, phenylalanine,
and methionine residues is also due to the low frequen-
cies of these amino acids within the library. An amino
acid position consensus was not evident from the 7-mer
library screening of Ni3B nanoparticles as substrates.However, besides the predominantly hydrophobic amino
acids (A and L) and hydrophilic amino acids (S and T)
the variety of amino acids with charged side groups im-
plies that these groups could be essential in specific
binding to both substrates via electrostatic interactions.
The Ni3B-binding peptides identified possess calculated
theoretical isoelectric points (pI) ranging from strongly
acidic (4.0) to highly basic (9.75). 60% of the peptides
binding to amorphous Ni3B show a pI value < 7.5 while
40% of the peptides have pI > 7.5. 57% of the peptides
binding to crystalline Ni3B show a pI value < 7.5 and
43% of the peptides have pI > 7.5. Therefore the identi-
fied peptides can be grouped into the categories acidic
(pI 3.0 - 5.9; 35.7% of the peptides), neutral (pI 6.0 – 8.9;
52.4% of the peptides), and basic (pI 9.0 – 12; 11.9% of
the peptides), respectively.
Relative binding affinity experiments
Because of the heterogeneity of all of the identified binding
peptides and the absence of a distinctive binding motif, the
binding strength of each of the 42 identified peptides to
amorphous (Figure 2A) and crystalline (Figure 2B) Ni3B was
determined by titer assays. Since previously binding affinity
experiments at pH 5 or pH 9 with a subset of the identified
binding peptides showed no increase in binding affinity
(data not shown) the relative binding affinity experiments
were carried out at pH 7. As a control to verify that the pep-
tide was the interactor of interest, M13KE wild-type
(M13wt) phage without a random peptide insert were com-
pared in the same manner as the peptide clones. As pre-
sented in Figure 2A, most of the phage clones, except C2
and C17, bind to amorphous Ni3B with greater affinity than
Table 2 Summary of the isolated binding peptides to crystalline Ni3B
Peptide Frequency Sequence Number of functionnal amino acid residues pI
Basic Acidic Hydrophobic
C15 1/28 LEQTPMF 0 1 3 4.00
C16 1/28 ELTQISS 0 1 2 4.00
C2 1/28 SDPQTHT 1 1 0 5.06
C3 1/28 TPPLLSP 0 0 2 5.19
C17 1/28 MNHAESY 1 1 2 5.22
C18 1/28 VPSLTPT 0 0 2 5.49
C4 1/28 VPIPYLP 0 0 4 5.49
C19 1/28 DPYNRIN 1 1 2 5.84
C20 1/28 RTFDAIS 1 1 3 5.84
C21 1/28 YELVLPK 1 1 4 6.00
C5 1/28 ETFPARG 1 1 2 6.10
C13 1/28 GPVNHQL 1 0 2 6.74
C22 1/28 LNHVLPA 1 0 4 6.74
C23 1/28 HAMRTEP 2 1 2 6.75
C6 1/28 ATSTAHA 1 0 3 6.79
C28 1/28 ANHQSAN 1 0 2 6.79
C10 1/28 SYTKLI-IL 2 0 3 8.33
C1 1/28 SPPKSNA 1 0 1 8.47
C9 1/28 SASKVHN 2 0 2 8.49
C24 1/28 SPSTHWK 2 0 1 8.49
C25 1/28 WNAKYTL 1 0 4 8.59
C12 1/28 YQVVPAR 1 0 4 8.75
C26 1/28 GDPKAAR 2 1 2 8.75
C11 1/28 GDHSRHK 4 1 0 8.76
C14 1/28 AGLPKHQ 2 0 2 8.80
C27 1/28 STFNSRV 1 0 2 9.47
C8 1/28 VHTNPSR 2 0 1 9.73
C7 1/28 GASATRT 1 0 2 9.75
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of 2 × 107 pfu/ml with amorphous Ni3B. Compared
with the M13wt phage, 9 out of 42 identified peptides
(see arrows in Figure 2A) bound on average 100-times
and 28 on average ten-times more efficiently to
amorphous Ni3B than the wild-type, verifying that bind-
ing to the substrate was a result of the peptide sequence
and not due to non-specific phage coat protein interac-
tions. The peptides A7, C12, and C15 (see arrows in
Figure 2B) bound on average 1000-times more efficiently
to crystalline Ni3B as compared to the M13wt phage,
which shows a binding affinity of 5 × 106 pfu/ml. Interest-
ingly, the phage clone A7 identified for amorphous Ni3B
shows a higher binding affinity to crystalline Ni3B than
most of the Ni3B-binding peptides (C1-C11, C13-C14,
and C16-C28) identified for crystalline Ni3B. In addition,
the amorphous Ni3B-binding peptides A8-A10 show ahigher binding affinity to crystalline Ni3B (≥10
9 pfu/ml)
than several binding peptides found for crystalline Ni3B
specifically (i.e. C1-C11, C13-C14, C16-C24, and C27-28).
The relative binding affinity experiments revealed a set of
several strong binders (>109 pfu/ml) for amorphous (A1-
A3, A7, C4, C9, C13, C15, and C24) and crystalline (A7,
C12, and C15) substrates (Table 4). The phages displaying
the peptides A7 and C15 emerged as the best binders for
both substrates.
Competitive binding assays of the best binding peptides
The competitive binding assay represents a method to
determine the most selective binding peptide sequence
from a large subset of phage display results [35]. To
identify a specifically recognised structural correlation
between the surfaces of amorphous and crystalline Ni3B
nanoparticles, the individual phage clones of the nine
Table 3 Occurrences of amino acids of the isolated Ni3B
binding peptides
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C24) to amorphous Ni3B as determined by the relative
binding affinity experiments were diluted into a single
mini-phage library. The mini-phage library was then
screened against amorphous or crystalline Ni3B sub-
strates. To receive better statistical results, the competi-
tive binding assays were repeated three-times. After a
single panning experiment, the strongly bound phages
were isolated and a total of 58 phage clones were ran-
domly selected and analysed by DNA sequencing to
identify the strongest binding peptides. In Tables 5 and 6
the most abundant sequence indicates the strongest
binding peptide to amorphous and crystalline Ni3B, re-
spectively. Among the 58 randomly chosen plaques, the
phage displaying the A7 peptide LGFREKE has the
strongest binding affinity to amorphous (seventeen-
times, ~58%) and crystalline (thirteen-times, ~45%)
Ni3B. Interestingly, the amino acids lysine, arginine, and
glutamic acid were shown to have a pronounced adhe-
sion of their charged side groups to amorphous Si3N4
and SiO2 under aqueous conditions [36]. It was also re-
ported, that the surface of amorphous Si3N4 may present
negative sites in solution [37]. Therefore substrates, pos-
sessing negatively surface charges in aqueous solution
with pH values less than the intrinsic pKa of the sidechain of a basic amino acid, a peptide containing basic
amino acids will be positively charged at these groups
and will provide an attractive interaction to the given
surface [36]. In aqueous solutions with higher pH values
than the intrinsic pKa of the side chain of an acidic
amino acid, a peptide containing acidic amino acids will
be negatively charged at these groups. Based on these
facts, the best binder A7 (LGFREKE) possesses in solu-
tion at pH 7 an alternating series of positively and nega-
tively charged side chains in its peptide sequence which
could be responsible for an interaction between the
charge depleted boron and the electrons accumulated on
the nickel side of amorphous and crystalline Ni3B nano-
particles. In contrast, the 7-mer peptide sequence
TNLTLAS, termed A1, which emerged as the dominant
amorphous Ni3B binder in the initial screening, pos-
sesses no charged side chain. The lack of electrostatic
interactions might contribute to the observed fact, that
it does not show the highest frequency in the competi-
tive assay.
Fluorescence microscopy of Ni3B-M13 complex
The binding of phage displaying the A7 peptide LGFREKE
to amorphous and crystalline Ni3B nanoparticles was con-
firmed by fluorescence microscopy. Amplified phage dis-
playing the LGFREKE peptide were incubated either with
amorphous or crystalline Ni3B nanoparticles and then
washed to remove the nonspecifically bound phage parti-
cles. The samples were then dyed using a fluorescently
tagged anti-M13 monoclonal antibody and washed again
to eliminate nonspecifically bound anti-M13 antibodies.
The fluorescence confocal images in Figure 3A and C
show the LGFREKE displaying phage binding to the
surface of amorphous and crystalline Ni3B nanoparti-
cles, respectively. Considerable fluorescence emits from
the surfaces of the LGFREKE phage-Ni3B nanoparticles.
Although the relative binding affinity experiments
showed an unspecific binding of the wild-type phage to
the Ni3B substrates, the control experiments (Figure 3E
and G) showed no fluorescence. This could be due to
the fact that the concentration of bound phage is below
the detection limit.
AFM measurements
To verify the interaction between M13 phage displaying
the A7 peptide on the p3 coat protein and Ni3B particles,
AFM measurements of phage bound to amorphous and
crystalline Ni3B particles were carried out (Figure 4). The
modified M13 phage were incubated either with amorph-
ous or crystalline nanoparticles as shown in Figure 4A and
B, respectively. As shown in Figure 4A and B the height of
the colour scale exceeds the height of the particles. This
colour scale was chosen to show the 100-nm-thick parti-
cles together with the 6-nm-thick phage. Individual phage
Figure 1 Amino acid distribution of the isolated peptide sequences. A total of 15 peptide sequences were analysed for amorphous Ni3B
(grey bars) and a total of 28 peptide sequences were analysed for crystalline Ni3B (black bars).
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This cross section and length of the modified phage cor-
respond to that of M13 wt phage (data not shown). Some
phage were oriented with their ends towards a nanoparti-
cle (see arrows in Figure 4), which implies an affinity be-
tween the modified phage proteins and the particle. There
are a few particles that seem to be attached to the un-
modified side of the phage. Possible explanations for this
observation include unspecific interaction or the presence
of more than one phage, i.e. bundles of phage where the
end of one phage coincides with the side of another phage.
A small level of unspecific interaction between nanoparti-
cles and phage cannot be avoided during preparation for
AFM imaging. The phage oriented with their ends to-
wards the nanoparticles, suggest that the peptide
LGFREKE interacts with both amorphous and crystalline
Ni3B nanoparticles.
Conclusions
Metal borides are inorganic solids that are very inter-
esting due to their high versatility in physical proper-
ties, as for example magnetism, electrical and thermal
conductivity, hardness and catalytic activity, but at the
same time they are difficult to prepare. Besides the ap-
plication as catalysts in all kinds of reduction reactions,
and hydrogenation reactions, metallic borides are
employed for the generation of conductive ceramics,
hard magnets, superconductors, and hard materials
[9-15,38-40]. Typical synthesis routes employ high re-
action temperatures and do not allow for a directed
synthesis of particles that are well-defined in terms of
size, shape, uniformity, phase purity, or crystallinity.Formation of metal boride nanoparticles in solvents has
been described occasionally, but an interaction of bo-
rides with biological material or bio-molecules like pep-
tides was unknown before [4,5]. To the best of our
knowledge, the present study is the first to identify pep-
tides that bind specifically to amorphous and to crystal-
line Ni3B nanoparticles. Although all identified peptide
sequences showed no significant binding motif, the
analysis of the resulting Ni3B-binding sequences found
them to be enriched in charged amino acids. The iden-
tified binding sequences possessed approximately three
times more positively charged than negatively charged
amino acids which leads to the assumption of electro-
static interactions between the identified binding pep-
tides and the Ni3B substrates. Fluorescence microscopy
and AFM studies directly confirmed the adhesion of
the best binding phage displaying the peptide LGFREKE
to amorphous and crystalline Ni3B particles. The best
binding peptide sequence could play an important role
for the development of a new synthesis route of Ni3B in
the presence of phage displaying the peptide, or the
synthetic peptide, respectively, which would represent a
complete new approach. The synthesis of Ni3B in the
presence of LGFREKE could result in mono-disperse
and peptide capped nanoparticles with well-defined and
uniform sizes and shapes exhibiting new catalytic and mag-
netic properties. Furthermore, the utilisation of M13 phage
as template for the Ni3B mineralisation could potentially
serve as a viable alternative to create tailor-made boride
composite materials by a biologically driven nano-assembly
synthesis and structuring for the generation of thermoelec-
tric devices and field effect transistors.
Figure 2 Evaluation of the binding strength of each of the 42 identified phage clones. The relative binding affinity of the phage clones to
amorphous (A) and crystalline (B) Ni3B nanoparticles was determined by titer assays at pH 7. The assay was repeated three-times for each clone and
the elucidated phage amounts were arithmetically averaged. As a control, M13KE wild-type (M13wt) phage without a random peptide insert were
compared in the same manner as the phage clones. Strong binding phage clones (> 109 pfu/ml) are indicated with an arrow. Clones identified on
amorphous Ni3B are designated with an A, clones identified on crystalline Ni3B are designated with a C.
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Phage and bacteria strains
Recombinant M13 phage from the Ph.D.-7 heptapeptide
library (New England Biolabs, MA) were amplified and






scribed by the manufacturer. M13KE wild-type (M13wt)
phage was used for the determination of unspecific bind-
ing to the Ni3B targets. Bacteria cultures were maintained
in lysogeny broth (LB) [41].
Peptide library screening
Ni3B-binding peptides were identified using a commer-
cially available M13 bacteriophage display library (Ph.D.-7;New England Biolabs) with random 7-mer peptides. The
DNA sequences of the 7-mer peptides are N-terminal fu-
sions to the minor coat protein p3 of the bacteriophage
M13. A short linker sequence (GGGS) separates each ran-
dom peptide from the minor coat protein p3. The phage
display library consists of approximately 1.28 × 109 differ-
ent peptides. The target binding, elution, and phage ampli-
fication steps were conducted according to the
manufacturer’s instructions. 20 mg of amorphous or crys-
talline Ni3B nanoparticles were used as targets. The targets
were washed three-times with Tris-buffered saline (TBS,
50 mM Tris–HCl, pH 7, and 150 mM NaCl) and blocked
with TBS supplemented with 5 mg/ml of BSA for 1 hour.
The blocked targets were then washed three-times with
TBS. To each target, a total number of 2 × 1011 phage in
Table 6 Competitive binding assay results for crystalline
Ni3B target
Peptide Sequence Frequency
A7 L G F R E K E 13/29
C9 S A S K V H N 5/29
C24 S P S T H W K 5/29
C13 G P V N H Q L 4/29
C4 V P I P Y L P 1/29
C15 L E Q T P M F 1/29
A1 T N L T L A S 0/29
A2 G A L P N N L 0/29
A3 S L A V S R S 0/29
Table 4 Strong binders identified by relative binding
affinity experiments
Ni3B amorphous target
# Peptide Frequency Phage titer (pfu/ml) Sequence pI
1 A7 1/30 6.1 × 109 L G F R E K E 6.14
2 A3 4/30 4.6 × 109 S L A V S R S 9.47
3 A2 6/30 3.8 × 109 G A L P N N L 5.52
4 C15 1/28 2.8 × 109 L E Q T P M F 4.00
5 C13 1/28 2.4 × 109 G P V N H Q L 6.74
6 C4 1/28 2.4 × 109 V P I P Y L P 5.49
7 C24 1/28 1.9 × 109 S P S T H W K 8.49
8 C9 1/28 1.8 × 109 S A S K V H N 8.49
9 A1 8/30 1.5 × 109 T N L T L A S 5.19
Ni3B crystalline target
# Peptide Frequency Phage titer (pfu/ml) Sequence pI
1 A7 1/30 5.1 × 109 L G F R E K E 6.14
2 C12 1/28 2.1 × 109 Y Q V V P A R 8.75
3 C15 1/28 1.8 × 109 L E Q T P M F 4.00
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bated for 1 hour. Non-specifically or weakly bound phage
particles were removed by washing ten-times with 0.1%
TBST. The remaining bound phage particles were eluted
with a solution containing 0.2 M glycine-HCl, pH 2.2 and
1 mg/ml BSA. After centrifugation, the supernatant was re-
moved from the target and neutralised with 1 M of Tris–
HCl, pH 9. The eluted phage were amplified through infec-
tion into E. coli ER2738, followed by purification by pre-
cipitation with polyethylene glycol according to the
manufacturer’s instructions. This completed a round of
panning. The entire biopanning process was repeated five
rounds to enrich for tight binders. To inhibit the hydro-
phobic interactions between the phage library and the
Ni3B targets, the concentration of Tween-20 was succes-
sively increased in each panning step from 0.1%, 0.3%,
0.5%, 0.6%, and 0.8%, respectively. After the fourth and fifthTable 5 Competitive binding assay results for amorphous
Ni3B target
Peptide Sequence Frequency
A7 L G F R E K E 17/29
C24 S P S T H W K 3/29
C9 S A S K V H N 2/29
C15 L E Q T P M F 2/29
A1 T N L T L A S 1/29
A2 G A L P N N L 1/29
C4 V P I P Y L P 1/29
C13 G P V N H Q L 1/29
A3 S L A V S R S 0/29round of screening, the eluted phage were diluted and ti-
trated on LB agar plates containing 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (Xgal) and isopropyl-β-D-
thiogalactopyranosid (IPTG). A total of 58 randomly
selected phage plaques, which appeared blue, were
picked and analysed by DNA sequencing. The phage
titer was determined by titration according to manufac-
turer’s recommendations using appropriate dilutions of
the precipitated phage.
Binding affinity assays
The binding affinity of each identified phage clone with the
Ni3B substrates was demonstrated by mixing equivalent
phage amounts (1 × 1010 pfu/ml) of individual phage clones
with either 20 mg of amorphous or crystalline Ni3B nano-
particles in 1 ml of TBS containing 0.8% Tween-20. After
1 hour incubation at room temperature the unbound phage
were removed by washing the substrates ten-times. Bound
phage were then isolated using the standard acidic elution
method as used in the screening procedure. For each clone,
the bound phage amount was elucidated by titration ac-
cording to manufacturer’s recommendations using appro-
priate dilutions of the eluted phage. The binding strength
of a single clone directly correlates with the phage titer of
the eluted phage. The assay was repeated three-times for
each clone and the elucidated phage titers were arithmetic-
ally averaged. M13KE wild-type phage, with no random
peptides displayed on the p3 protein, was used as a control.
Competitive binding assays
The phages with the highest binding affinity to either
amorphous or crystalline Ni3B were evaluated by the
method of a competitive binding assay. For this assay, the
individual phage clones of the nine strongest binders on
amorphous Ni3B as determined by binding affinity assays,
were separately amplified and diluted into a mini-phage li-
brary at a concentration of 1 × 107 pfu/μl per clone. Subse-
quently 1 × 1010 pfu/ml of this minimised phage library
was applied to amorphous or crystalline Ni3B nanoparticles
Figure 4 Visualisation of the phage binding by atomic force
microscopy. Topographic AFM images of the binding of modified
M13 phage (LGFREKE) to amorphous (A) and crystalline (B) Ni3B
nanoparticles. The AFM images of M13 phage displaying the A7
peptide on p3 showed the phage to bind to several amorphous and
crystalline Ni3B nanoparticles at the tip of p3, which are indicated by
arrows. The colour scale exceeds the particle height to better display
the particle cross section.
Figure 3 Analysis of the phage binding by fluorescence
microscopy. Confocal fluorescence (A, C) and transmission optical
microscopy (B, D) of LGFREKE phage bound to amorphous (A, B) and
crystalline (C, D) Ni3B nanoparticles. The samples were dyed using a
fluorescently tagged anti-M13 monoclonal antibody. Confocal fluores-
cence (E, G) and transmission optical microscopy (F, H) of the control
experiments of amorphous and crystalline Ni3B nanoparticles, respect-
ively, which were preincubated with M13KE wild-type (M13wt) phage
before incubation with the fluorescently tagged antibody.
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says. After a single panning round, the weakly bound
phages were removed by washing the substrates and the
remaining strongly bound phages were isolated using the
standard acidic elution method as used in the screening
procedure. The eluted phages were quantified by titration
according to the manufacturer’s recommendations. The
assay was repeated three-times for each substrate. A total
number of 29 plaques were randomly picked for each sub-
strate and sequenced to reveal the most strongly binding
peptide sequences.
Synthesis and characterisation of amorphous and
crystalline Ni3B
The Ni3B nanoparticles were synthesised from NaBH4
(Alfa Aesar, 97%) and NiCl2 × 6 H2O (Grüssing GmbH,98%) in aqueous solution at about 0°C following a synthe-
sis route described earlier [5]. According to this procedure
amorphous Ni3B is formed primarily, which is trans-
formed into the crystallised Ni3B sample at 490°C in vac-
uum (5 × 10-3 mbar, 18 h). The X-ray diffraction pattern
of the annealed, crystalline sample allows for its identifica-
tion as Ni3B (see Additional file 1). In previous work, we
have shown using methods like X-ray diffraction, energy-
dispersive X-ray spectroscopy, X-ray absorption spectros-
copy, scanning and transmission electron microscopy, and
energy-loss electron spectroscopy that the corresponding
amorphous phase actually consists of the same boride as
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the amorphous Ni3B nanoparticles were used after exten-
sive washing with deionized water and drying in a desicca-
tor under vacuum. The crystalline nanoparticles were
obtained from the amorphous product after the annealing
process and used directly.
Fluorescence microscopy analysis
The binding of M13 phage to amorphous and crystalline
nickel boride nanoparticles was characterised with a Zeiss
Axiovert 200 inverted fluorescence microscope equipped
with a Zeiss AxioCam HRm. The fluorescence images were
taken using emission at 528 nm. M13 phage were incu-
bated with 10 mg of amorphous and crystalline Ni3B nano-
particles at a concentration of 3 × 1012 pfu/ml in 1 ml TBS
supplemented with 0.8% Tween-20. After 2 h at room
temperature, unbound phage were removed by washing
the substrates three-times withTBS. Subsequently, the sub-
strates were blocked with TBS supplemented with 2% BSA
and 0.05% Tween-20 for 1 hour and washed three-times
with TBS supplemented with 0.05% Tween-20. The sam-
ples were dyed using a FITC tagged anti-M13 monoclonal
antibody against phage coat protein p8 (Acris Antibodies,
Inc., Herford, Germany). Each target was incubated for
1 hour with 1 μg/ml of labeled monoclonal antibodies in
TBS with 0.05% Tween-20. After removing unbound anti-
bodies by washing the samples three-times with TBS con-
taining 0.05% Tween-20, the samples were analysed by
fluorescence microscopy.
Atomic force microscopy (AFM) analysis
Ni3B nanoparticles, phages and compounds of phages
with Ni3B were characterised with an atomic force
microscope (AFM). The measurements were carried
out on a Dimension Icon AFM with a Nanoscope V
controller (Bruker, Santa Barbara, California) in ambi-
ent conditions. The measurements were performed in
tapping mode, to minimise the lateral interaction. Sili-
con cantilevers (PPP NCH, Nanosensors) with a nom-
inal resonance frequency of 330 kHz, spring constant of
42 Nm-1, and a nominal tip diameter of less than
10 nm were used. All images were taken at a resolution
of 512 × 512 pixel2. M13 phages were incubated with
10 mg of amorphous and crystalline Ni3B nanoparticles
at a concentration of 3 × 1012 pfu/ml in 1 ml TBS sup-
plemented with 0.8% Tween-20. After 2 h, unbound
phages were removed by washing the substrates three-
times with TBS. Samples were prepared by dropping
the sample suspension on a silicon wafer or freshly
cleaved mica. The samples were dried in a stream of
dry nitrogen. Image analysis and processing was per-
formed with the Nanoscope Analysis software Version
1.40 (Bruker). A plane correction procedure and a line
by line fit were used to compensate for the sample tilt.Additional file
Additional file 1: X-ray powder diffraction profile. Calculated (solid
blue line) and difference (solid red line) X-ray powder diffraction profiles
for the Rietveld refinement of crystalline Ni3B. Reflection positions are
marked (blue bars).
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